human | Q5 |
P8446 | Gateway to Research person ID | 74EB61BE-2699-4B95-BFB7-BDCC5F67DDD5 |
P10283 | OpenAlex ID | A5102841485 |
P496 | ORCID iD | 0000-0002-6233-6410 |
P1053 | ResearcherID | A-6636-2010 |
P185 | doctoral student | Ayesha Verrall | Q91250224 |
P734 | family name | van Crevel | Q108004191 |
van Crevel | Q108004191 | ||
van Crevel | Q108004191 | ||
P735 | given name | Reinout | Q2187196 |
Reinout | Q2187196 | ||
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | NZThesisProject | Q111645234 |
P21 | sex or gender | male | Q6581097 |
Q31044800 | A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians |
Q38363794 | Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus |
Q35091998 | Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia |
Q125886143 | Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial |
Q46729405 | Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations |
Q33986542 | Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia |
Q43060160 | Application of spoligotyping to noncultured Mycobacterium tuberculosis bacteria requires an optimized approach |
Q33280355 | Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia |
Q37530766 | Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia |
Q35377891 | Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer |
Q30375629 | BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. |
Q38274692 | BCG-induced protection: effects on innate immune memory |
Q37374103 | BCG-induced trained immunity in NK cells: Role for non-specific protection to infection |
Q34300368 | Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes |
Q34552339 | Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia |
Q48507319 | Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study. |
Q30888623 | Challenges in delivering HIV-care in Indonesia: experience from a referral hospital |
Q30888427 | Characteristics of subjects counseled and tested for HIV in an Indonesian hospital; factors associated with HIV-status and CD4 cell-count. |
Q36349886 | Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia |
Q46057964 | Clinical experience with the combined use of lopinavir/ritonavir and rifampicin |
Q35240921 | Clinical management of concurrent diabetes and tuberculosis and the implications for patient services |
Q34055185 | Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries |
Q34252123 | Common variants at 11p13 are associated with susceptibility to tuberculosis |
Q34532738 | Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia |
Q38801426 | Correction for Bekkering et al., "In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes". |
Q34376260 | Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study |
Q34667619 | Cost-effectiveness of scaling up voluntary counselling and testing in West-Java, Indonesia |
Q33744330 | Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia |
Q35794458 | Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease |
Q34057772 | Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation |
Q30810448 | Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation |
Q30234697 | Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms |
Q36453623 | Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids |
Q33265416 | Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment |
Q92926695 | Early Clearance of Mycobacterium tuberculosis Is Associated With Increased Innate Immune Responses |
Q89968033 | Establishing the cascade of care for patients with tuberculous meningitis |
Q43203258 | Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis |
Q34561741 | Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes |
Q37238784 | Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock |
Q36783226 | GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last |
Q21092470 | Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis |
Q34430198 | Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis |
Q37061098 | Harnessing the beneficial heterologous effects of vaccination |
Q35094823 | Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, Indonesia |
Q35592853 | Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower ex-vivo production of CCR5 ligands |
Q28545281 | Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals |
Q100752776 | High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study) |
Q40096008 | High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets |
Q33653641 | High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia |
Q61443141 | Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study |
Q37525436 | Immunometabolic Pathways in BCG-Induced Trained Immunity |
Q34689226 | Implementation of LED fluorescence microscopy for diagnosis of pulmonary and HIV-associated tuberculosis in a hospital setting in Indonesia |
Q33721305 | Implications of the global increase of diabetes for tuberculosis control and patient care |
Q33287264 | Improved diagnosis of tuberculosis by better sputum quality |
Q41160326 | Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment |
Q30888729 | Improving diagnosis of pulmonary tuberculosis among HIV/AIDS patients: literature review and experience in a teaching hospital in Indonesia. |
Q39298239 | In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes |
Q30888678 | Indonesian prisons and HIV: part of the problem, part of the solution? |
Q112642715 | Induction of trained immunity by influenza vaccination - impact on COVID-19 |
Q35081725 | Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia |
Q34587177 | Innate immunity to Mycobacterium tuberculosis |
Q30888477 | Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia |
Q34458735 | Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial |
Q45455937 | Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi |
Q45492819 | Intravenous drug use and the spread of HIV; an international perspective |
Q37296702 | Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study |
Q33283091 | Iron deficiency and NRAMP1 polymorphisms (INT4, D543N and 3'UTR) do not contribute to severity of anaemia in tuberculosis in the Indonesian population |
Q34729493 | Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients |
Q89968037 | Knowledge gaps and research priorities in tuberculous meningitis |
Q36349908 | Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia |
Q37620298 | Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity |
Q40828543 | Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity |
Q34327505 | Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation |
Q30555347 | Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype |
Q35069064 | Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia |
Q100693889 | Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits |
Q40404556 | Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes |
Q46653612 | More on tuberculosis. |
Q42364862 | Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol |
Q33523135 | Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia |
Q43124577 | Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. |
Q33374785 | Mycobacterium tuberculosis population structures differ significantly on two Indonesian Islands |
Q24811631 | NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis |
Q57176505 | Non-specific effects of vaccines: Current evidence and potential implications |
Q46331629 | Numbers needed to treat to prevent tuberculosis |
Q36104396 | Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients |
Q33282527 | Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients |
Q33521011 | Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes |
Q114054838 | Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination |
Q34241113 | Polymorphisms in SP110 are not associated with pulmonary tuberculosis in Indonesians |
Q34374038 | Polymorphisms in autophagy genes and susceptibility to tuberculosis |
Q33527616 | Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains |
Q35908648 | Predominance of modern Mycobacterium tuberculosis strains and active transmission of Beijing sublineage in Jayapura, Indonesia Papua |
Q30888595 | Prevention and treatment of HIV addicted patients: a biopsychosocial approach |
Q26851747 | Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions |
Q42695119 | Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response". |
Q40072252 | Reply to Neeradi et al and Dhawan and Sankhyan |
Q33544827 | Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia |
Q37456438 | Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells |
Q44092850 | Rifampicin and moxifloxacin for tuberculous meningitis--authors' reply |
Q90429615 | Role of Glutamine Metabolism in Host Defense Against Mycobacterium tuberculosis Infection |
Q35942752 | Routine or targeted HIV screening of Indonesian prisoners |
Q34097635 | SNP/RD typing of Mycobacterium tuberculosis Beijing strains reveals local and worldwide disseminated clonal complexes |
Q30888509 | Screening and diagnosis of HIV-infection in Indonesia: one, two or three tests? |
Q33658539 | Sensitivity of the quantiferon-gold in-tube assay in sputum smear positive TB cases in Indonesia |
Q34953130 | Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia |
Q40679421 | Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir |
Q34537809 | Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality |
Q91299310 | T Cell Metabolism Has Evolved to Tolerate Tuberculosis |
Q39547504 | TANDEM: understanding diabetes and tuberculosis |
Q24678506 | TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans |
Q119684385 | The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms Both Adaptive and Innate Immune Responses |
Q35559840 | The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity |
Q33505477 | The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study |
Q35558240 | The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis |
Q33291134 | The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis |
Q30248586 | The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? |
Q34615423 | The influence of influenza virus infections on the development of tuberculosis |
Q34740235 | The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study |
Q38017483 | The role of autophagy in host defence against Mycobacterium tuberculosis infection |
Q52606949 | Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis. |
Q34007595 | Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting |
Q34172027 | Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study. |
Q114869936 | Trained Immunity as a Preventive Measure for Surgical Site Infections |
Q95295198 | Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection |
Q104135153 | Trained immunity, tolerance, priming and differentiation: distinct immunological processes |
Q38312182 | Trained immunity: consequences for the heterologous effects of BCG vaccination |
Q38543488 | Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines |
Q40402758 | Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes. |
Q33970633 | Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period |
Q38847398 | Unravelling the nature of non-specific effects of vaccines-A challenge for innate immunologists |
Q34748343 | Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia |
Q35863177 | Women with HIV in Indonesia: are they bridging a concentrated epidemic to the wider community? |
Q91250224 | Ayesha Verrall | doctoral advisor | P184 |
Q111965870 | Innate Factors in Early Clearance of Mycobacterium tuberculosis | thesis committee member | P9161 |
Search more.